T. Chambers

发表

C. Rice, B. Lindenbach, T. Chambers, 1987, Microbiological sciences.

Flavivirus genome organization, expression, and replication.

C. Rice, C. Hahn, T. Chambers, 1990, Annual review of microbiology.

Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein.

R J Fletterick, R C Weir, R. Fletterick, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function.

T. Chambers, H. Krishna Murthy, D. Droll, 2000, Virology.

The flaviviruses : pathogenesis and immunity

T. Monath, T. Chambers, 2003 .

Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation.

C. Rice, A. Grakoui, T. Chambers, 1989, The New biologist.

The flaviviruses: structure, replication and evolution.

T. Monath, T. Chambers, 2003 .

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

T. Monath, T. Chambers, T. Tsai, 1997, Vaccine.

Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis.

C. Rice, T. Chambers, D. McCourt, 1989, Virology.

Pathogenesis of flavivirus encephalitis

M. Diamond, T. Chambers, 2003, Advances in Virus Research.

Neuroadapted Yellow Fever Virus 17D: Genetic and Biological Characterization of a Highly Mouse-Neurovirulent Virus and Its Infectious Molecular Clone

T. Chambers, M. Nickells, 2001, Journal of Virology.

Hepatitis C Patients Naive , Resting Phenotype in a Subset of Accumulation of B Lymphocytes with a Rice

C. Rice, I. Jacobson, A. Bisceglie, 2003 .

HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.

T. Chambers, A. D. Di Bisceglie, Xiaofeng Fan, 2004, Virology.

Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responder

T. Chambers, A. D. Di Bisceglie, Xiaofeng Fan, 2006, Journal of medical virology.

Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication

C. Rice, S. M. Amberg, T. Chambers, 1993, Journal of virology.

Yellow Fever Virus Encephalitis: Properties of the Brain-Associated T-Cell Response during Virus Clearance in Normal and Gamma Interferon-Deficient Mice and Requirement for CD4+ Lymphocytes

T. Chambers, Ting Liu, 2001, Journal of Virology.

FLA \lIVIRUS GENOME ORGJ\NIZATION, EXPRESSION, AND REPLICATION

C. Rice, C. Hahn, T. Chambers, 1990 .

Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities.

K. Murthy, T. Chambers, D. Droll, 2005, The Journal of general virology.

Mutagenesis of the yellow fever virus NS2B/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication

C. Rice, T. Chambers, A. Nestorowicz, 1995, Journal of virology.

Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties

C. Rice, P. Mason, T. Chambers, 1999, Journal of Virology.

Recombination and flavivirus vaccines: a commentary.

J. H. Strauss, M. Cetron, S. Halstead, 2005, Vaccine.

Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection

A. Dibisceglie, T. Chambers, Xiaofeng Fan, 2005, Journal of Virology.

Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence.

C. Rice, T. Chambers, R. Galler, 1996, Virology.

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.

A. Barrett, F. Guirakhoo, T. Monath, 1999, Virology.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

A. Barrett, F. Guirakhoo, T. Monath, 1999, Vaccine.

The flaviviruses: detection, diagnosis and vaccine development.

T. Monath, T. Chambers, 2003 .

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients 1

C. Rice, I. Jacobson, J. Ni, 2003, The Journal of Immunology.

West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness.

C. Rice, S. Lustig, T. Chambers, 1998, The Journal of general virology.

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

Andrew H Talal, David Butera, C. Rice, 2005, Blood.

in patients with hepatitis C Plasma chemokine levels correlate with the outcome of antiviral therapy

C. Rice, I. Jacobson, A. Bisceglie, 2013 .

Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates

F. Guirakhoo, T. Monath, K. Soike, 2000, Journal of Virology.

Yellow Fever Virus

T. Chambers, 2002 .

Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites

C. Rice, A. Grakoui, T. Chambers, 1991, Journal of virology.

Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera.

C. Rice, T. Chambers, D W McCourt, 1990, Virology.

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.

W. Wold, Xiaoshan Jiang, T. Chambers, 2006, The Journal of general virology.

Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)

F. Guirakhoo, T. Monath, T. Chambers, 2001, Journal of Virology.

Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model

J. Schlesinger, A. Davidson, Xiaoshan Jiang, 2003, Journal of Virology.

West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein.

W. Wold, T. Chambers, D. Droll, 2008, The Journal of general virology.

JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease.

W. Wold, Xiaoshan Jiang, T. Chambers, 2007, Virology.

Flaviviruses: General Features

T. Chambers, 2008 .

Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model

W. Wold, T. Chambers, D. Droll, 2008, Journal of Virology.

Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice

T. Chambers, M. Nickells, 2003, Journal of Virology.

Neuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus Spread

T. Chambers, Leonsia A Vlaycheva, 2002, Journal of Virology.

Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.

T. Chambers, D. Droll, M. Nickells, 2004, Virology.

Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site

C. Rice, C. Lin, S. M. Amberg, 1993, Journal of virology.

Flavivirus, Infection and Immunity

T. Chambers, 1998 .

Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.

C. Rice, T. Chambers, A. Nestorowicz, 1994, Virology.

Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing.

C. Rice, C. Lin, T. Chambers, 1993, Virology.

Neuroblastoma cell-adapted yellow fever virus: mutagenesis of the E protein locus involved in persistent infection and its effects on virus penetration and spread.

T. Chambers, D. Droll, M. Nickells, 2005, The Journal of general virology.